Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of British Columbia

$27,000.00

Harnessing Regulatory T cells to prevent fibrosis after heart transplantation

FY 2025-26

Summary
Heart transplantation is the only life-saving option for people with severe heart failure. In Canada, approximately 160 heart transplants are performed every year. While short-term (1-year) survival has improved, many patients still face long-term complications that damage the new heart. One major problem is cardiac fibrosis, a process where scar-like tissue builds up in the heart, making it stiff and unable to contract and pump properly. The initiation of cardiac fibrosis is driven by inflammation after transplant surgery. An immune molecule called IL-1 plays a key role in driving cardiac fibrosis, and blocking IL-1 in mouse models has been shown to reduce scarring and improve heart function. Regulatory T cells (Tregs) are immune cells that modulate immune responses. The Levings lab has developed a way to engineer Tregs so they can recognize the transplant organ, protect it from immune attack, and thus prevent transplant rejection. My project aims to engineer and generate transplant-specific Tregs that, upon activation, will also release an IL-1-blocking protein to further limit inflammation and fibrosis. This dual-action cell therapy is intended to both prevent rejection and reduce fibrosis in the transplanted heart, offering more durable protection and better long-term outcomes for patients.
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
572842
Name
Kong Qing Ru
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Harnessing Regulatory T cells to prevent fibrosis after heart transplantation
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Cardiac Fibrosis; Cell Engineering; Chimeric Antigen Receptors; Heart Transplantation; Immunotherapy; Interleukin-1 Pathway; Regulatory T Cell; Translational Research
Abstract
Heart transplantation is the only life-saving option for people with severe heart failure. In Canada, approximately 160 heart transplants are performed every year. While short-term (1-year) survival has improved, many patients still face long-term complications that damage the new heart. One major problem is cardiac fibrosis, a process where scar-like tissue builds up in the heart, making it stiff and unable to contract and pump properly. The initiation of cardiac fibrosis is driven by inflammation after transplant surgery. An immune molecule called IL-1 plays a key role in driving cardiac fibrosis, and blocking IL-1 in mouse models has been shown to reduce scarring and improve heart function. Regulatory T cells (Tregs) are immune cells that modulate immune responses. The Levings lab has developed a way to engineer Tregs so they can recognize the transplant organ, protect it from immune attack, and thus prevent transplant rejection. My project aims to engineer and generate transplant-specific Tregs that, upon activation, will also release an IL-1-blocking protein to further limit inflammation and fibrosis. This dual-action cell therapy is intended to both prevent rejection and reduce fibrosis in the transplanted heart, offering more durable protection and better long-term outcomes for patients.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kong, Qing Ru
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~